Chen Ting, Yao Li, Fan Xiaoqin, Zhu Chunyan
Intensive Care Unit, The Second People's Hospital of Hefei.
Intensive Care Unit, The First Affiliated Hospital of USTC, University of Science and Technology of China, Anhui, China.
Medicine (Baltimore). 2021 Jan 8;100(1):e24235. doi: 10.1097/MD.0000000000024235.
Catheter-related thrombosis is a serious complication of lung transplantation under venovenous extracorporeal membrane oxygenation (ECMO). Although ECMO-related thrombosis is not uncommon, there are few reports of giant hollow catheter thrombosis in lung transplantation under venovenous ECMO (ECMO). Blood loss and transfusion of coagulation factors may promote ECMO-related thrombosis. Hollow catheter thrombus was not detected on ultrasonography performed after initiation of ECMO. Therefore, it is essential to identify, manage, and reduce or avoid such thrombosis.
We report a rare case of a 43-year-old man with advanced silicosis who developed a massive hollow catheter thrombus during lung transplantation. Anticoagulant therapy did not affect the size of the thrombus.
Giant hollow catheter thrombosis was diagnosed by ultrasonography. Thrombosis from the right external iliac vein to the inferior vena cava was found in the shape of the ECMO pipe.
Heparin was prescribed as an anticoagulant.
Anticoagulant therapy did not affect the size of the thrombus during 2 weeks. The patient developed an infection and died of multiple organ failure.
It is uncommon for massive hollow thrombus to occur during venovenous-ECMO-assisted lung transplantation. Fibrinogen and prothrombin complexes promote the formation of thrombus, and the measurement of the wall thickness of ECMO catheter may help to detect such thrombus.
导管相关血栓形成是静脉-静脉体外膜肺氧合(ECMO)支持下肺移植的严重并发症。虽然ECMO相关血栓形成并不罕见,但静脉-静脉ECMO支持下肺移植中巨大中空导管血栓形成的报道较少。失血和凝血因子输注可能会促进ECMO相关血栓形成。在启动ECMO后进行的超声检查未检测到中空导管血栓。因此,识别、处理并减少或避免此类血栓形成至关重要。
我们报告了1例罕见的43岁晚期矽肺男性患者,在肺移植期间发生了巨大中空导管血栓。抗凝治疗并未影响血栓大小。
通过超声检查诊断为巨大中空导管血栓形成。发现从右髂外静脉至下腔静脉的血栓呈ECMO管道形状。
给予肝素作为抗凝剂。
抗凝治疗在2周内未影响血栓大小。患者发生感染,死于多器官功能衰竭。
静脉-静脉ECMO辅助下肺移植期间发生巨大中空血栓并不常见。纤维蛋白原和凝血酶原复合物会促进血栓形成,测量ECMO导管壁厚度可能有助于检测此类血栓。